Cellectar Biosciences, Inc. Current Liabilities
Cellectar Biosciences, Inc. (CLRB) had Current Liabilities of $5.24 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-13
- 2026-06-30: Liabilities, Current $5.24M.
- 2026-03-31: Liabilities, Current $4.87M.
- 2025-12-31: Liabilities, Current $4.75M.
- 2025-09-30: Liabilities, Current $4.91M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $5.24M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $4.87M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $4.75M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $4.91M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $5.87M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $6.02M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $9.39M 10-K · filed 2026-03-04 | |
| 2024-09-30 | $20.31M 10-Q · filed 2024-11-18 | |
| 2024-06-30 | $15.17M 10-Q · filed 2024-10-29 | |
| 2024-03-31 | $28.55M 10-Q/A · filed 2024-10-29 | $16.27M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $25.36M 10-K · filed 2025-03-13 | $12.94M 10-K · filed 2024-03-27 |
| 2023-09-30 | $29.84M 10-K/A · filed 2024-10-29 | $16.47M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $12.98M 10-K/A · filed 2024-10-29 | $6.45M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $11.54M 10-K/A · filed 2024-10-29 | $6.96M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $11.50M 10-K/A · filed 2024-10-29 | $5.53M 10-K · filed 2023-03-09 |
| 2022-09-30 | $7.12M 10-K/A · filed 2024-10-29 | $6.52M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $6.51M 10-K/A · filed 2024-10-29 | $5.61M 10-Q · filed 2022-08-05 |
| 2022-03-31 | $7.35M 10-K/A · filed 2024-10-29 | $4.65M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $3.99M 10-K · filed 2023-03-09 | |
| 2021-09-30 | $3.17M 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $3.52M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $5.02M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $3.56M 10-K · filed 2022-03-21 | |
| 2020-09-30 | $3.96M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $3.32M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $3.05M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $2.77M 10-K · filed 2021-03-02 | |
| 2019-09-30 | $2.98M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $2.67M 10-Q · filed 2019-08-12 | |
| 2019-03-31 | $2.20M 10-Q · filed 2019-05-06 | |
| 2018-12-31 | $1.62M 10-K · filed 2020-03-09 | |
| 2018-09-30 | $2.66M 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $2.29M 10-Q · filed 2018-08-10 | |
| 2018-03-31 | $2.11M 10-Q · filed 2018-05-11 | |
| 2017-12-31 | $2.11M 10-K · filed 2019-02-26 | |
| 2017-09-30 | $2.13M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $1.59M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $1.40M 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $1.63M 10-K · filed 2018-03-21 | |
| 2016-09-30 | $1.43M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $1.39M 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $2.81M 10-Q · filed 2016-05-12 | |
| 2015-12-31 | $5.70M 10-K · filed 2017-03-15 | |
| 2015-09-30 | $5.48M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $5.84M 10-Q · filed 2015-08-12 | |
| 2015-03-31 | $5.90M 10-Q · filed 2015-05-20 | |
| 2014-12-31 | $6.23M 10-K/A · filed 2016-10-20 | $2.18M 10-K · filed 2015-03-24 |
| 2014-09-30 | $5.34M 10-Q · filed 2015-05-20 | $2.07M 10-Q · filed 2014-11-12 |
| 2014-06-30 | $4.08M 10-Q · filed 2014-08-04 | |
| 2014-03-31 | $4.41M 10-Q · filed 2014-05-14 | |
| 2013-12-31 | $4.52M 10-Q · filed 2015-05-20 | |
| 2013-09-30 | $4.63M 10-Q · filed 2013-11-13 | |
| 2013-06-30 | $6.09M 10-Q · filed 2013-08-12 | |
| 2013-03-31 | $6.59M 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $732.69K 10-K · filed 2014-03-19 | |
| 2012-09-30 | $736.79K 10-Q · filed 2012-11-06 | |
| 2012-06-30 | $635.72K 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $506.30K 10-Q · filed 2012-05-04 | |
| 2011-12-31 | $503.58K 10-K · filed 2013-03-28 | |
| 2011-09-30 | $521.82K 10-Q · filed 2011-11-07 | |
| 2011-06-30 | $449.49K 10-Q · filed 2011-08-12 | |
| 2010-12-31 | $904.82K 10-K · filed 2012-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |